Skip to content

Laparoscopic Splenectomy in Children

Prognostic Scoring System of Laparoscopic Splenectomy in Children With Benign Hematological Diseases.

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04763733
Acronym
splenectomy
Enrollment
137
Registered
2021-02-21
Start date
2012-01-02
Completion date
2021-02-16
Last updated
2021-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Blood Diseases, Children, Laparoscopic Splenectomy

Keywords

laparoscopic splenectomy,, children, prognostic score, benign hematological diseases

Brief summary

Laparoscopic splenectomy (LS) gained popularity since it has been described for the first-time during nineties of past century. It has become golden method for splenectomy in all ages including children

Detailed description

Background: laparoscopic splenectomy (LS) gained popularity during the last years in pediatric age group. Benign hematological diseases represent the main indications of that procedure. There are some score systems of difficulty of the technique but they are for adult patients. The aim is to develop a prognostic score system of LS in children with benign hematological diseases. Methods: LS was performed in all children with benign hematological diseases. LS was done by the same team. They operated children in lateral decubitus position. The control of pedicle was achieved using bipolar sealing devices, polymer clips or endoscopic linear staplers. Preoperative, operative, and postoperative data were recorded and analyzed. Children were divided into two groups A and B according to the development of complications.

Interventions

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* children with benign hematological diseases

Exclusion criteria

* malignant hematological diseases

Design outcomes

Primary

MeasureTime frameDescription
prognosis of procedurefrom day 0 to 7 daysnumber of patients with peritoneal collections, number of patients having pancreatitis, number of patients staying more than two days postoperative

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026